KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Construction in Progress (2016 - 2025)

Merck (MRK) has disclosed Construction in Progress for 17 consecutive years, with $9.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Construction in Progress rose 14.8% to $9.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $9.2 billion, a 14.8% increase, with the full-year FY2025 number at $9.2 billion, up 14.8% from a year prior.
  • Construction in Progress was $9.2 billion for Q4 2025 at Merck, up from $8.0 billion in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $9.2 billion in Q4 2022 to a low of $8.0 billion in Q4 2024.
  • A 5-year average of $8.6 billion and a median of $8.3 billion in 2021 define the central range for Construction in Progress.
  • Peak YoY movement for Construction in Progress: rose 19.3% in 2021, then dropped 10.06% in 2023.
  • Merck's Construction in Progress stood at $8.3 billion in 2021, then rose by 10.5% to $9.2 billion in 2022, then decreased by 10.06% to $8.3 billion in 2023, then decreased by 3.36% to $8.0 billion in 2024, then rose by 14.8% to $9.2 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Construction in Progress are $9.2 billion (Q4 2025), $8.0 billion (Q4 2024), and $8.3 billion (Q4 2023).